Suppr超能文献

在携带t(11;17)(q13;q21)易位的急性非早幼粒细胞白血病中鉴定出一种新型RAB6A::TOP2A融合基因。

Identification of a novel RAB6A::TOP2A fusion in acute non-promyelocytic leukemia harboring t(11;17)(q13;q21) translocation.

作者信息

Su Zhan, Du Yahui, Yuan Chenglu, Zhao Xianzhi, Zhang Xiaoshan, Cui Hongqing, Yue Ting, Zhao Hongguo, Wang Wei

机构信息

Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.

Department of Hematology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, 266035, China.

出版信息

Virchows Arch. 2024 Aug 26. doi: 10.1007/s00428-024-03853-1.

Abstract

Fusion genes generally serve as driver mutations in leukemia. The rearrangement of the RARA gene located on chromosome 17q21 is a molecular pathological feature of acute promyelocytic leukemia (APL). A series of RARA-involved fusion genes have been identified in variant APL, including one carrying the t(11;17)(q13;q21) translocation, resulting in the NUMA1::RARA fusion gene. Here, we present an interesting case where blasts carry the t(11;17)(q13;q21), but the cell morphology does not exhibit signs of promyelocytic differentiation. Transcriptome sequencing identified a novel fusion gene, RAB6A::TOP2A, with a frameshift mutation in the reading frame. The patient did not respond to all-trans retinoic acid (ATRA) treatment.

摘要

融合基因通常在白血病中作为驱动突变。位于17q21染色体上的RARA基因重排是急性早幼粒细胞白血病(APL)的分子病理特征。在变异型APL中已鉴定出一系列涉及RARA的融合基因,包括一种携带t(11;17)(q13;q21)易位的基因,导致NUMA1::RARA融合基因。在此,我们展示了一个有趣的病例,其中原始细胞携带t(11;17)(q13;q21),但细胞形态未表现出早幼粒细胞分化的迹象。转录组测序鉴定出一个新的融合基因RAB6A::TOP2A,其阅读框中存在移码突变。该患者对全反式维甲酸(ATRA)治疗无反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验